Sativa Wellness Group is pleased to announce that it has submitted its Novel Food application for validation by the Food Standards Agency (“FSA”) ahead of the 31 March 2021 deadline, as part of the Company’s ongoing commitment to continually deliver the highest level of regulatory compliance and product quality – ‘CBD you can trust’.
Further to the Company’s news release dated January 29, 2021 regarding the Annual General and Special Meeting of the shareholders held on January 26, 2021 (the “Meeting”), each of Geremy Thomas and George Thomas have been appointed as directors, and Geremy Thomas has been appointed as Executive Chairman of the Board.
The shareholders unanimously voted to set the number of directors at six. Each of Henry Lees-Buckley and Jason Dussault declined their respective nominations as a Director of the Company.
Although the world is still in the grip of the global COVID pandemic, the Company has held steadfast in our commitment to building a long-term growth company in the European CBD and wellness space. Our commitment to producing and distributing the highest quality and compliant products and services to the market also remains.
Sativa Wellness (AQSE and CSE: SWEL) notes today’s announcement by the Aquis Stock Exchange PLC, that the two new segments of the market have come into force. Please see Aquis Stock Exchange link for the full announcement.
Sativa Wellness has been notified by AQSE that it qualifies for the “Apex” segment of the AQSE Growth Market. In order to be eligible for admission to Apex, Sativa has succeeded in meeting, amongst other things, the following specific criteria…
Sativa Wellness (AQSE and CSE: SWEL) notes today’s announcement by the Aquis Stock Exchange PLC, that the two new segments of the market have come into force. Please see Aquis Stock Exchange link for the full announcement.
Sativa Wellness has been notified by AQSE that it qualifies for the “Apex” segment of the AQSE Growth Market. In order to be eligible for admission to Apex, Sativa has succeeded in meeting, amongst other things, the following specific criteria…
“Sativa Wellness welcomes the clarity that these regulatory updates bring to the CBD wellness and medicinal cannabis industry in Europe, the US and globally. We believe that a well-regulated cannabis sector will lead to consumers benefitting from safe, compliant and quality products, such as our Goodbody CBD brands, and opens the pathway for patients to benefit from further research into the efficacy of medicinal cannabis…
We are pleased to announce that the board of directors have resolved to change the Company’s fiscal year end from July 31 to December 31, effective immediately.
By moving the Company’s reporting cycle to a calendar quarter basis in line with the operating subsidiaries of the Company, Sativa Wellness aims to reduce the time constraints and administrative expenses with having to reconcile multiple reporting periods among other related corporations.
In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 30 September 2020, being the last business day prior to the date of this announcement, it had 302,592,941 common shares of no par value each in issue and admitted to trading on the AQSE Growth Market. Sativa Wellness holds no common shares in treasury…
The European Union’s highest court has ruled that CBD (Cannabidiol) is not a narcotic drug, and that a French ban on hemp derived CBD contradicts EU law. This ruling has opened the door for high quality compliant CBD companies to operate in markets across the EU. The Sativa Wellness Group Inc. welcomes this news as the company operates CBD extraction and production facilities in the UK and Europe…
We are pleased to announce that as part of Sativa Wellness’s commitment to safety and wellness in our communities, we are launching a private COVID testing clinic inside our Goodbody Wellness store in Bath on 19th November.
The clinic will be providing PCR testing for travel and work, antigen testing (results in 15 minutes) as well as antibody testing for those who want to find out if they have had COVID 19 and to see if they have developed antibodies…
Sativa Wellness (AQSE and CSE: SWEL), the fully integrated European seed to consumer CBD group with the pricing, products, and stability to meet the growing CBD market demand both now and in the medium term, wishes to announce that the Company has secured a cannabidiol (“CBD”) product listings with the “Health Store”. The Health Store is the longest established and most respected distributer in the health food industry, who supply over 800 stores in England and Ireland and a further 130 overseas retailer stores in more than 30 different countries.